These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16989264)

  • 41. Strategies for immunization against invasive Haemophilus influenzae type b infection.
    Iwarson S
    Vaccine; 1991 Jun; 9 Suppl():S35-7; discussion S42-3. PubMed ID: 1891955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
    Walls T; Cho V; Martin N; Williman J; Brunton C
    Pediatr Infect Dis J; 2018 Oct; 37(10):1041-1047. PubMed ID: 30222697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience.
    Findlow H; Borrow R
    Paediatr Drugs; 2016 Apr; 18(2):83-7. PubMed ID: 26913860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine.
    Salleras L; Domínguez A; Cardeñosa N
    Vaccine; 2003 Jan; 21(7-8):729-33. PubMed ID: 12531350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Haemophilus Influenzae infection before and after the immunization campaign among children in the Valencia community (1996-2000)].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2002; 76(3):197-206. PubMed ID: 12092466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries.
    Kamara L; Lydon P; Bilous J; Vandelaer J; Eggers R; Gacic-Dobo M; Meaney W; Okwo-Bele JM
    Health Policy Plan; 2013 Jan; 28(1):11-9. PubMed ID: 22411879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project.
    Tozzi AE; Piga S; Corchia C; Di Lallo D; Carnielli V; Chiandotto V; Fertz MC; Miniaci S; Rusconi F; Cuttini M
    Vaccine; 2014 Feb; 32(7):793-9. PubMed ID: 24397902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
    Ladhani S; Slack MP; Heys M; White J; Ramsay ME
    Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.
    Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM
    Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
    Parikh SR; Andrews NJ; Beebeejaun K; Campbell H; Ribeiro S; Ward C; White JM; Borrow R; Ramsay ME; Ladhani SN
    Lancet; 2016 Dec; 388(10061):2775-2782. PubMed ID: 28100432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
    Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
    Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Global routine vaccination coverage, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1367-71. PubMed ID: 21030941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
    Sáfadi MA; McIntosh ED
    Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.
    Trotter CL; Ramsay ME; Kaczmarski EB
    Commun Dis Public Health; 2002 Sep; 5(3):220-5. PubMed ID: 12434692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.
    Welte R; Trotter CL; Edmunds WJ; Postma MJ; Beutels P
    Pharmacoeconomics; 2005; 23(9):855-74. PubMed ID: 16153131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies.
    Grabowsky M; Nobiya T; Selanikio J
    Trop Med Int Health; 2007 Jul; 12(7):815-22. PubMed ID: 17596247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.